Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

UIC researchers receive $1.7 million NCI grant to study Southeast Asian fruit

UIC researchers receive $1.7 million NCI grant to study Southeast Asian fruit

Rutgers study finds gene responsible for spread of prostate cancer

Rutgers study finds gene responsible for spread of prostate cancer

Researchers find how GREB1 gene promotes resistance to prostate cancer treatments

Researchers find how GREB1 gene promotes resistance to prostate cancer treatments

Molecular hallmarks of tumor hypoxia across 19 cancer types discovered

Molecular hallmarks of tumor hypoxia across 19 cancer types discovered

Scientists discover mutational signatures of tumor hypoxia

Scientists discover mutational signatures of tumor hypoxia

Aggressive prostate cancer linked to hereditary breast cancer, confirms study

Aggressive prostate cancer linked to hereditary breast cancer, confirms study

Northwestern Medicine receives $10 million gift to create new institute for urologic cancers

Northwestern Medicine receives $10 million gift to create new institute for urologic cancers

Study finds increase in suicide risk after cancer diagnosis

Study finds increase in suicide risk after cancer diagnosis

Traditional and new imaging methods used for prostate cancer diagnosis

Traditional and new imaging methods used for prostate cancer diagnosis

Scientists discover two therapies that slow progression of pediatric leukemia in mice

Scientists discover two therapies that slow progression of pediatric leukemia in mice

CWRU researcher receives nearly $1 million to study drug resistance mechanisms in prostate cancer

CWRU researcher receives nearly $1 million to study drug resistance mechanisms in prostate cancer

Interval of time to biochemical failure could be used as surrogate endpoint for prostate cancer

Interval of time to biochemical failure could be used as surrogate endpoint for prostate cancer

Black men diagnosed with low-grade prostate cancer have higher risk of death, study shows

Black men diagnosed with low-grade prostate cancer have higher risk of death, study shows

New computer model helps predict course of the disease in prostate cancer patients

New computer model helps predict course of the disease in prostate cancer patients

Prostate cancer detection using MRI now first-line investigation tool

Prostate cancer detection using MRI now first-line investigation tool

Surgical treatment unnecessary for many prostate cancer patients

Surgical treatment unnecessary for many prostate cancer patients

Faster, cheaper test has potential to enhance prostate cancer evaluation

Faster, cheaper test has potential to enhance prostate cancer evaluation

Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer

Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer

New computer model predicts prostate cancer progression

New computer model predicts prostate cancer progression

Men with inflammatory bowel disease have higher prostate cancer risk

Men with inflammatory bowel disease have higher prostate cancer risk